- Clinical Trials
- March 2025
- 280 Pages
Global
From €2730EUR$3,000USD£2,341GBP
- Report
- May 2024
- 131 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Report
- April 2022
- 112 Pages
Global
From €1820EUR$2,000USD£1,560GBP
Ocular Hypertension Drug is a type of cardiovascular drug used to treat increased pressure in the eye. It is used to reduce the risk of developing glaucoma, a condition that can lead to vision loss. Ocular Hypertension Drugs work by reducing the amount of fluid produced in the eye, which helps to reduce the pressure. Common side effects include dry eyes, blurred vision, and headaches.
Ocular Hypertension Drugs are available in both prescription and over-the-counter forms. Prescription drugs are typically used for more severe cases, while over-the-counter drugs are used for milder cases. The market for Ocular Hypertension Drugs is growing as more people are diagnosed with glaucoma and other eye conditions.
Some companies in the Ocular Hypertension Drug market include Allergan, Bausch + Lomb, Merck, Novartis, and Pfizer. Show Less Read more